We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Initial results of a study with a bioabsorbable metal stent show that the novel
device works as intended -- to prop open blocked leg arteries before being
fully absorbed into the artery wall, so that complications common with standard
stents don't occur.
ZOLL Medical announced the results of two clinical studies that were completed
in out-of-hospital settings that provide evidence that the ZOLL AutoPulse Noninvasive
Cardiac Support Pump helps to increase short-term survival in cardiac arrest
patients.
Eyeonics, the developer of the crystalens, the first and only FDA-approved accommodating
intraocular lens, has announced that more than 13,000 crystalens were implanted
in the U.S. during the company's first year in the U.S. market.
Acceleration Therapeutics has announced that a published study using its AT-101
passive exercise device showed, for the first time, that the AT-101 produces
an important benefit that also occurs with active exercise.
Unilens Vision has announced the launch of a new soft, multifocal toric contact
lens that will provide astigmatic patients, who now have presbyopia, with all-day
comfort, ease of fit and optimum visual acuity at every distance.
ManthaMed, a Canadian distributor devoted to the promotion of diagnostic testing
designed to detect and monitor certain medical conditions, has added another
medical device to its product line.
Milestone Scientific announced that the results of a second independent pilot
clinical study have confirmed the efficacy of its CompuFlo pressure/force computer-controlled
anesthetic delivery system in determining the pressure of the epidural space.
Thermage, a maker of innovative aesthetic devices based on proprietary radiofrequency
technology, characterized the countersuit filed Jan. 10 by Syneron as without
merit.
Abbott will begin enrolling patients during the first quarter of 2005 in its
asymptomatic carotid trial, ACT I. The first trial of its kind, this multicenter,
randomized trial will compare carotid artery stenting to carotid artery surgery
in asymptomatic patients -- those who have not displayed symptoms of a stroke
but are at-risk -- who normally would be referred for surgery.